CCMW
EW icon

Cypress Capital Management (Wyoming)’s Edwards Lifesciences EW Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30
Closed -$14K – 218
2019
Q2 		$14K Sell
30
-30
-50% -$1.81K 0.02% 173
2019
Q1 		$38K Buy
+60
New +$3.42K 0.05% 125

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s EW Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) held its Edwards Lifesciences (EW) position steady in Q2 2026 at 780 shares worth $70.6K. The position accounts for 0.06% of the portfolio, ranked #93.

Cypress Capital Management (Wyoming) first reported a position in EW in Q2 2017 and has held it in 29 quarters since. The position peaked at $5.61M in Q4 2019. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Cypress Capital Management (Wyoming) held 780 shares of Edwards Lifesciences worth $70.6K as of Q2 2026.
  • Cypress Capital Management (Wyoming) left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.06% of Cypress Capital Management (Wyoming)'s portfolio in Q2 2026, its #93 holding.
  • Cypress Capital Management (Wyoming) first reported a position in Edwards Lifesciences in Q2 2017 and has held it in 29 quarters since.
  • Cypress Capital Management (Wyoming)'s Edwards Lifesciences position peaked at $5.61M in Q4 2019.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.